Concepedia

Bellinda Benhamú

BB

42

Publications

1.5K

Citations

24

H-Index

1994

Active since

Affiliations

Universidad Complutense de Madrid(Current)

Universitat Autònoma de Barcelona

Universidad Nacional de Educación a Distancia

Universitat de Barcelona

Spanish National Cancer Research Centre

Bellinda Benhamú is an author at Universidad Complutense de Madrid specializing in medicine, pharmacology, and biochemistry.

ORCID

Top concepts

Publications per year

1994–2022

42

Publications

42

Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity

Teresa Puig, Carlos Turrado, Bellinda Benhamú et al. · Clinical Cancer Research · 2009 · 95 citations

, , +13

A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines

Teresa Puig, Helena Aguilar, Sílvia Cufí et al. · Breast Cancer Research · 2011 · 94 citations · Full text

A Three-Dimensional Pharmacophore Model for 5-Hydroxytryptamine<sub>6</sub>(5-HT<sub>6</sub>) Receptor Antagonists

María L. López-Rodrı́guez, Bellinda Benhamú, T. de la Fuente et al. · Journal of Medicinal Chemistry · 2005 · 89 citations · Full text

Optimization of the Pharmacophore Model for 5-HT<sub>7</sub>R Antagonism. Design and Synthesis of New Naphtholactam and Naphthosultam Derivatives

María L. López-Rodrı́guez, Esther Porras, M. J. MORCILLO et al. · Journal of Medicinal Chemistry · 2003 · 70 citations · Full text

Synthesis and Structure−Activity Relationships of a New Model of Arylpiperazines. 2. Three-Dimensional Quantitative Structure−Activity Relationships of Hydantoin−Phenylpiperazine Derivatives with Affinity for 5-HT<sub>1A</sub> and α<sub>1</sub> Receptors. A Comparison of CoMFA Models

María L. López-Rodrı́guez, M. Luisa Rosado, Bellinda Benhamú et al. · Journal of Medicinal Chemistry · 1997 · 64 citations · Full text

Rows per page

1–5 of 42